Skip to content

Corporate brand

Unclaimed

Curium is the world leader in radiopharmaceuticals, focused on nuclear medicine.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Curium is a global nuclear medicine company that develops, manufactures, and supplies radiopharmaceutical products. It claims to be the world leader in radiopharmaceuticals, with a legacy since the 1960s and serving customers in over 60 countries. The company is headquartered in Paris, France.

History

Curium has a long and proven legacy of serving the radiopharmaceutical market since the 1960s. The company states it has held the title of global leader in nuclear medicine since 2017. The name 'Curium' honors the legacy of Marie and Pierre Curie, after whom the radioactive element curium was named.

Products and positioning

World leader in radiopharmaceuticals, 100% focus on nuclear medicine.

Product categories. generators · cold kits · hot products · auxiliary products

Recent events

  • Curium completes acquisition of Abscint SA[6]

    Curium announced that it completed the acquisition of Abscint SA, gaining global rights to develop, manufacture and commercialize the investigational PET radiodiagnostic tracer ABS-011.

  • Reported

    Curium plans to rebrand Zevacor Molecular business[7]

    Curium said the Zevacor Molecular business will be rebranded under the Curium name; the source describes this as a future plan.

Read more

Sources7 sources

Cite this profile: Cite the canonical profile. /brand-wiki/curium · Editorial policy · How profiles are compiled